|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable and contract assets, net of allowance for credit losses | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, at cost (note 2) | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets not subject to amortization (note 4): | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Trademarks | ||||||||||||||||||||
| Intangible assets not subject to amortization | ||||||||||||||||||||
| Intangible assets subject to amortization, net (note 4) | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Deferred merchant and other payables | ||||||||||||||||||||
| Current portion of debt, including $324 million measured at fair value as of December 31, 2024 (note 5) | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Series A Preferred Stock liability (note 8) | ||||||||||||||||||||
| Accrued liabilities and other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, including zero and $287 million measured at fair value as of December 31, 2024 and December 31, 2023, respectively (note 5) | ||||||||||||||||||||
| Deferred income tax liabilities (note 7) | ||||||||||||||||||||
| Financial instrument liabilities (note 3) | ||||||||||||||||||||
| Series A Preferred Stock liability (note 8) | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Common stock value | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive earnings (loss), net of taxes | ||||||||||||||||||||
| Retained earnings (deficit) | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Noncontrolling interests in equity of subsidiaries | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
